In a blog post today, APA CEO and Medical Director Saul Levin, M.D., M.P.A., marked the 25th anniver...

The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...

Citicoline reduced cocaine use and was well tolerated by patients with bipolar disorder, according t...

A combination of the antipsychotic olanzapine and the antidepressant fluoxetine proved superior to p...

People with serious mental illnesses such as schizophrenia or bipolar disorder are at greater risk f...

Though research has shown some psychiatric populations to be at risk for disadvantages involving fer...

While studies using functional magnetic resonance imaging (fMRI) have begun to investigate the neura...

Antidepressant monotherapy in patients with bipolar disorder appears to be associated with an increa...

Both childhood traumas and ones that occur later in life appear to contribute to the initial onset o...